Rapid, reliable, and validated testing for High-Risk HPV

Cervical cancer is the second most common type of cancer in women (the first being breast cancer) with an estimated 12,000+ new cases and more than 4,000 deaths in the US each year. It has been shown that cervical cancer has a close tie to HPV (Human papillomavirus, shown here). There are 14 high-risk HPV types; the two most common (HPV types 16 and 18) cause approximately 70% of cervical cancers. Therefore, developing a quick, early, and easy way to detect high-risk HPV is critical for women’s healthcare.

QuanDx’s MeltPro High-Risk HPV Genotyping Assay (Multi-Color Melting Curve Analysis) is qualitative in vitro test used for HPV genotyping and cervical cancer screening. This test uses PCR followed by high-resolution melting curve analysis for the detection of 14 high-risk HPV types. High-risk HPV subtypes can be differentiated in one single reaction.

This assay has been widely validated in clinical labs (see the References below for the details).

• Accurate: Clinical trial data indicated that the total coincidence rate was above 99%.

• Easy to handle: Ready-to-use lyophilized reagent. Single tube reaction.

• Easy to ship and storage in the dry format: No dry ice required.

• Rapid: After DNA extraction, test results are obtained in 2.5 hours.

• Comprehensive: Kit covers all 14 high-risk HPV types.

• Reliable: The

CE-Marked for IVD sale in Europe; Product not FDA cleared.